Markets / IPO / Sai Parenteral's

Sai Parenteral's IPO

Updated 18:56

Mainboard IPO on NSE and BSE · Pharmaceuticals

Status

Listed

Price band

₹372–392

Lot size

38 shares · ₹14,896

Subscribed

1.05×

How it listed

Issue price

₹392

Listing price (open)

₹400.00 +2.04%

First-day close

₹405.70 +3.49%

Price now

₹466.35 +18.97%

Listing day	2 Apr 2026
Open / high / low / close	₹400.00 / ₹416.00 / ₹400.00 / ₹405.70
Shares traded on NSE	10,52,029
Market value at the listing-day close	₹25,325 cr

Closing prices since listing: 26 Oct ₹455.65, 27 Oct ₹478.25, 28 Oct ₹484.05, 29 Oct ₹505.70, 30 Oct ₹521.95, 2 Nov ₹480.70, 3 Nov ₹469.25, 4 Nov ₹478.50, 5 Nov ₹482.95, 6 Nov ₹467.00.

Sai Parenteral's share price, live chart and technicals →

Key dates

Bidding opens	24 Mar 2026
Bidding closes	27 Mar 2026
Allotment	30 Mar 2026
Refunds and shares in demat	1 Apr 2026
Listing	2 Apr 2026

Issue reservation

Investor group	Shares	% of issue	Most applicants allotted
Institutions (QIB)	21,12,900	28.09%	–
HNI / NII	16,22,876	21.57%	–
HNI, above ₹10 lakh	10,81,918	14.38%	418
HNI, ₹2–10 lakh	5,40,958	7.19%	1,016
Retail	37,86,710	50.34%	99,650

Shares NSE lists as offered to each group, plus the anchor portion. "Most applicants allotted" is how many people can get the minimum application in that group when it is oversubscribed.

Lot size by investor type

Application	Lots	Shares	Amount
Retail (minimum)	1	38	₹14,896
Retail (maximum)	13	494	₹1,93,648
Small HNI (minimum)	14	532	₹2,08,544
Small HNI (maximum)	67	2,546	₹9,98,032
Big HNI (minimum)	68	2,584	₹10,12,928

At ₹392 a share. Retail bids go up to ₹2 lakh, small HNI from ₹2 lakh to ₹10 lakh, big HNI above ₹10 lakh.

Chance of getting shares (retail)

Every valid retail application should get shares. The retail portion was subscribed 0.12×.

Subscription

Investor category	Shares offered	Shares bid for	Times subscribed
Institutions (QIB)	21,12,900	36,10,266	1.71×
HNI / NII	16,22,876	38,31,502	2.36×
HNI, above ₹10 lakh	10,81,918	37,07,318	3.43×
HNI, ₹2–10 lakh	5,40,958	1,24,184	0.23×
Retail	37,86,710	4,39,204	0.12×
Total	75,22,486	78,80,972	1.05×

NSE and BSE bids together, as of 27 Mar 2026 19:00.

Demand at each price

Top price ₹392	74.99 lakh shares	95.1%
Cut-off final price, whatever it is; mostly retail	3.50 lakh shares	4.4%
Lower prices ₹372–391	0.33 lakh shares	0.4%

Shares bid on NSE and BSE at each price in the band. Most bids at the top price, and little at lower prices, means buyers were keen.

Anchor investors

Anchor bid date	23 Mar 2026
Lock-in ends for the first 50% (30 days)	28 Apr 2026
Lock-in ends for the remaining 50% (90 days)	27 Jun 2026

Anchor investors are large funds that buy the day before the IPO opens. SEBI locks in half their shares for 30 days from the allotment and the rest for 90 days; they can sell from the next trading day. Traders watch these dates because extra selling can come in.

Financials and valuation

	At issue price	Now
Market value	₹24,470 cr	₹29,111 cr
P/E (last 12 months' profit)	981.5	1,167.7

Revenue, last 12 months	₹668 cr
Profit, last 12 months	₹25 cr
Return on equity	5.0%
Debt to equity	0.72

From results the company filed with NSE (latest period to 30 Sept 2026). Twelve-month figures need four quarters of results, so they fill in over the first year after listing.

Other recent IPOs: Pharmaceuticals

Company	Listed	Subscribed	On listing	Since IPO
Symbiotec Pharmalab	1 Sept	71.26×	0.00%	+53.20%
Bio Medica Laboratories SME	29 May	–	-20.00%	+4.57%
KRM Ayurveda SME	29 Jan	–	+27.48%	+68.89%
Corona Remedies	15 Dec	137.04×	+38.42%	+129.86%
Curis Lifesciences SME	14 Nov	–	+14.14%	+38.36%
Rubicon Research	16 Oct	103.90×	+27.84%	+242.12%
Amanta Healthcare	9 Sept	82.61×	+7.14%	+54.98%
Anlon Healthcare	3 Sept	7.13×	-89.89%	-70.33%

IPO details

Price band	₹372–392
Final issue price	₹392
Lot size	38 shares
Minimum investment	₹14,896 (1 lot)
Market	NSE mainboard
Issue type	100% Book Building
Face value	₹5 per Equity Share
Industry	Pharmaceuticals
Issue size	₹408.79 crore (about 1.04 crore shares) · Fresh issue + offer for sale: fresh ₹285.00 cr, offer for sale ₹123.79 cr
ISIN	INE0H9F01037
Registrar	Bigshare Services Private Limited Helpline: +91 22 62638200, ipo@bigshareonline.com
Lead managers	Arihant Capital Markets Limited
Prospectus	Red herring prospectus (NSE)

Check allotment status

Allotment was finalised on 30 Mar 2026. Check it on the registrar's page (Bigshare Services Private Limited), NSE or BSE with your PAN or application number.

← All IPOs: open, upcoming and recently listed

From NSE's official IPO data. Expected dates follow SEBI's T+3 timetable; the exchange confirms them. Information only, not investment advice.

What is the Sai Parenteral's IPO price band and lot size?

The price band is ₹372–392 per share, and one lot is 38 shares (₹14,896 at the upper price).

When is the Sai Parenteral's IPO allotment date?

Allotment was finalised on 30 Mar 2026, the next working day after bidding closed on 27 Mar 2026.

How many times was the Sai Parenteral's IPO subscribed?

In total 1.05 times, on NSE and BSE together; retail 0.12 times.

What is the Sai Parenteral's IPO listing date?

It listed on 2 Apr 2026 on NSE and BSE.

What is the chance of getting Sai Parenteral's IPO shares?

The retail portion was not oversubscribed, so every valid retail application should get shares.

When does the Sai Parenteral's anchor lock-in end?

The 30-day lock-in on half of the anchor investors' shares ends on 28 Apr 2026 and the 90-day lock-in on the rest ends on 27 Jun 2026; they can sell from the next trading day.

What was the Sai Parenteral's listing gain?

It opened at ₹400.00 against an issue price of ₹392, a gain of 2.04%. It is now up 18.97% from the issue price.